X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14926) 14926
Book Review (1590) 1590
Newsletter (1590) 1590
Publication (620) 620
Conference Proceeding (28) 28
Book Chapter (20) 20
Newspaper Article (20) 20
Magazine Article (14) 14
Dissertation (13) 13
Transcript (4) 4
Book / eBook (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12467) 12467
humans (12175) 12175
female (7861) 7861
leucovorin (7792) 7792
male (7721) 7721
oncology (7505) 7505
middle aged (6912) 6912
antineoplastic combined chemotherapy protocols - therapeutic use (6500) 6500
aged (6338) 6338
leucovorin - administration & dosage (5984) 5984
adult (5417) 5417
fluorouracil - administration & dosage (5296) 5296
fluorouracil (5160) 5160
chemotherapy (4896) 4896
cancer (4349) 4349
colorectal neoplasms - drug therapy (3734) 3734
colorectal cancer (3596) 3596
treatment outcome (3100) 3100
oxaliplatin (2926) 2926
leucovorin - therapeutic use (2699) 2699
antineoplastic combined chemotherapy protocols - adverse effects (2684) 2684
5-fluorouracil (2619) 2619
colorectal neoplasms - pathology (2554) 2554
care and treatment (2372) 2372
organoplatinum compounds - administration & dosage (2184) 2184
fluorouracil - therapeutic use (2131) 2131
antineoplastic combined chemotherapy protocols - administration & dosage (2123) 2123
camptothecin - analogs & derivatives (2047) 2047
research (1899) 1899
aged, 80 and over (1823) 1823
neoplasm staging (1797) 1797
irinotecan (1795) 1795
metastasis (1791) 1791
fluorouracil - adverse effects (1758) 1758
drug administration schedule (1738) 1738
carcinoma (1670) 1670
disease-free survival (1574) 1574
adenocarcinoma - drug therapy (1543) 1543
camptothecin - administration & dosage (1532) 1532
surgery (1526) 1526
prognosis (1515) 1515
bevacizumab (1510) 1510
leucovorin - adverse effects (1508) 1508
survival rate (1506) 1506
therapy (1442) 1442
1st-line treatment (1407) 1407
liver neoplasms - secondary (1406) 1406
trial (1370) 1370
chemotherapy, adjuvant (1356) 1356
survival (1348) 1348
methotrexate - administration & dosage (1336) 1336
neoplasm metastasis (1336) 1336
combined modality therapy (1310) 1310
retrospective studies (1283) 1283
survival analysis (1282) 1282
pharmacology & pharmacy (1225) 1225
colon cancer (1218) 1218
folinic acid (1175) 1175
capecitabine (1165) 1165
oncology, experimental (1159) 1159
liver neoplasms - drug therapy (1113) 1113
colonic neoplasms - drug therapy (1099) 1099
organoplatinum compounds - therapeutic use (1093) 1093
deoxycytidine - analogs & derivatives (1076) 1076
animals (1055) 1055
medicine & public health (1053) 1053
colorectal neoplasms - mortality (1035) 1035
abridged index medicus (995) 995
metastatic colorectal-cancer (956) 956
drugs (950) 950
antineoplastic agents - therapeutic use (939) 939
organoplatinum compounds - adverse effects (937) 937
follow-up studies (928) 928
infusions, intravenous (906) 906
cisplatin - administration & dosage (864) 864
combination (856) 856
time factors (850) 850
antineoplastic agents (838) 838
antimetabolites, antineoplastic - administration & dosage (827) 827
drug therapy (827) 827
colorectal-cancer (819) 819
dose-response relationship, drug (812) 812
randomized-trial (812) 812
methotrexate (806) 806
deoxycytidine - administration & dosage (795) 795
analysis (788) 788
phase-ii (781) 781
cetuximab (778) 778
colonic neoplasms - pathology (774) 774
prospective studies (774) 774
stomach neoplasms - drug therapy (765) 765
antimitotic agents (762) 762
cisplatin (760) 760
drug therapy, combination (758) 758
rectal neoplasms - drug therapy (739) 739
antimetabolites, antineoplastic - therapeutic use (733) 733
adenocarcinoma - pathology (724) 724
fluorouracil - analogs & derivatives (724) 724
adolescent (701) 701
radiotherapy (689) 689
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14776) 14776
Japanese (806) 806
German (275) 275
French (252) 252
Chinese (130) 130
Italian (115) 115
Spanish (75) 75
Russian (37) 37
Korean (23) 23
Hungarian (22) 22
Polish (12) 12
Danish (10) 10
Dutch (10) 10
Czech (9) 9
Finnish (3) 3
Norwegian (3) 3
Portuguese (3) 3
Hebrew (2) 2
Lithuanian (2) 2
Romanian (2) 2
Serbian (2) 2
Swedish (2) 2
Bulgarian (1) 1
Icelandic (1) 1
Persian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15, pp. 1723 - 1731
Journal Article
Annals of Oncology, ISSN 0923-7534, 05/2005, Volume 16, Issue 5, pp. 762 - 766
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1609 - 1618
In patients with metastatic colon cancer, fluorouracil, oxaliplatin, and irinotecan plus bevacizumab, as compared with fluorouracil and irinotecan plus... 
1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INFUSIONAL FLUOROURACIL | LEUCOVORIN | MANAGEMENT | PHASE-III | GUIDELINES | IRINOTECAN | OXALIPLATIN | CHEMOTHERAPY | FOLFIRI | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Treatment outcome | Care and treatment | Analysis | Colorectal cancer | Dosage and administration | Leucovorin | Fluorouracil | Colorectal carcinoma | Diarrhea | Metastasis | Survival | Patients | Clinical outcomes | Metastases | Irinotecan | Stomatitis | Chemotherapy | Neurotoxicity | Oxaliplatin | Monoclonal antibodies | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 862 - 873
Summary Background Since the 1990s, fluorouracil-based adjuvant chemotherapy has significantly reduced the risk of tumour recurrence in patients with stage III... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST-LINE TREATMENT | THERAPY | ONCOLOGY | BEVACIZUMAB | ADJUVANT TREATMENT | NSABP C-07 | KRAS | COMBINATION | METASTATIC COLORECTAL-CANCER | CHEMOTHERAPY | ras Proteins - genetics | Colonic Neoplasms - genetics | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Colonic Neoplasms - drug therapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Diarrhea - chemically induced | Colonic Neoplasms - surgery | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Infusions, Intravenous - adverse effects | Adult | Female | Leucovorin - therapeutic use | Adenocarcinoma - genetics | Chemotherapy, Adjuvant | Cetuximab | Antibodies, Monoclonal, Humanized - adverse effects | Drug Eruptions - etiology | Exons - genetics | Proto-Oncogene Proteins - genetics | Adenocarcinoma - drug therapy | Mucositis - chemically induced | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colonic Neoplasms - pathology | Intention to Treat Analysis | Aged | Neoplasm Staging | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Adenocarcinoma - surgery | Prevention | Care and treatment | Chemotherapy | Colon cancer | Hospitals | Leucovorin | Product development | Cancer | Index Medicus | Life Sciences
Journal Article
Annals of Oncology, ISSN 0923-7534, 2014, Volume 25, Issue 7, pp. 1346 - 1355
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 9, pp. 853 - 860
Summary Background Fluorouracil and folinic acid with either oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) are widely used as first-line or second-line... 
Hematology, Oncology and Palliative Medicine | TRIAL | CAPECITABINE | 1ST-LINE TREATMENT | INFUSIONAL FLUOROURACIL/LEUCOVORIN | THERAPY | ONCOLOGY | 5-FLUOROURACIL/FOLINIC ACID | FLUOROPYRIMIDINES | OXALIPLATIN | III NONINFERIORITY | FAILURE | Prodrugs - administration & dosage | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Fluorouracil - analogs & derivatives | Tegafur - adverse effects | Kaplan-Meier Estimate | Oxonic Acid - administration & dosage | Adenocarcinoma - drug therapy | Oxonic Acid - adverse effects | Disease-Free Survival | Prodrugs - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tegafur - administration & dosage | Aged | Drug Combinations | Adenocarcinoma - mortality | Medical colleges | Chemotherapy | Oncology, Experimental | Colorectal cancer | Leucovorin | Research | Metastasis | Cancer | Fluorouracil | Analysis | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2008, Volume 26, Issue 12, pp. 2013 - 2019
Journal Article